SecBot SecBot
425 ·Filed Sep 24, 2026

MDT

Medtronic plc
NEUTRAL
Impact 3/10
Horizonweeks Processed1mo ago SEC0001628280-26-063443
Rule 425 M&A communications
Actionable Insight • Neutral

Monitor for the actual exchange offer launch and any changes to the 225,361,295 share exchange cap. The consistent pattern of identical administrative filings suggests the separation process is on track but not yet complete.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20
Entry
$88.64
T+0 close · Sep 24, 2026 · via day close
Latest settled
+7.64%
T+20 · $95.41 · next T+60 in 5w
Vs SPY
+9.11%
α at T+20
Latest observation
+12.95%
T+34 · FF3 residual α
  1. T+0 · Sep 25 $88.64entry
  2. T+1 · 7w ago +0.97%α +1.71% · $89.50
  3. T+5 · 7w ago −2.55%α −2.33% · $86.38
  4. T+20 · 25d ago +7.64%α +9.11% · $95.41
  5. T+36 · todayOpen
  6. T+60 · in 5w Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Medtronic filed a Rule 425 communication confirming the ongoing maintenance of a dedicated website (hosted by D.F. King) for the MiniMed exchange offer, where Medtronic will exchange up to 225,361,295 newly issued MiniMed shares for Medtronic ordinary shares. This is a routine administrative filing supporting the ongoing separation process, no new financial data, no changes to deal terms, and no opposition disclosed.

Key Facts

  • Medtronic is maintaining a dedicated website at httpswww.dfking.com/MDTSeparation for the MiniMed exchange offer
  • The exchange offer involves up to 225,361,295 newly issued shares of MiniMed Group, Inc. common stock
  • This is the fourth consecutive 425 filing in the past week confirming the same website and exchange offer details

Financial Impact

No financial impact, routine administrative filing with no new financial data or changes to deal terms

Risk Factors

  • No new information or changes to deal terms disclosed
  • Multiple identical filings may indicate a prolonged administrative process

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
425 Filing (Primary)0001628280-26-063443
Document: 0001628280-26-063443-index-headers.html0001628280-26-063443
Document: 0001628280-26-063443-index.html0001628280-26-063443
Document: 0001628280-26-063443.txt0001628280-26-063443

Track record

53 reports on MDT

Performance horizon

5 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +15.30% at T+60 after the Jun 3, 2026 report. 9 of 11 went positive at some point.

Filters
  1. Nov 16, 2026today Press Release Neutral 4/10 Entry price pending
  2. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $101.59 Now $102.88 +1.27% settles Feb 8
  3. Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $98.88 Now $102.88 +4.05% settles Feb 1
  4. Oct 19, 202628d ago 8-K Neutral 4/10 Entry $94.63 Now $102.88 +8.72% settles Jan 15
  5. Oct 16, 20264w ago Insider Cluster Bearish 5/10 Entry $92.77 Now $102.88 −10.90% settles Jan 14
  6. Oct 16, 20264w ago Insider Cluster Bearish 5/10 Entry $92.77 Now $102.88 −10.90% settles Jan 14
  7. Oct 15, 20264w ago 144 Neutral 3/10 Entry $95.45 Now $102.88 +7.78% settles Jan 12
  8. Oct 14, 20264w ago SC TO-I/A Neutral 5/10 Entry $94.23 Now $102.88 +9.18% settles Jan 11
  9. Oct 14, 20264w ago 425 Neutral 5/10 Entry $94.23 Now $102.88 +9.18% settles Jan 11
  10. Oct 13, 20264w ago SC TO-I/A Neutral 5/10 Entry $93.01 Now $102.88 +10.61% settles Jan 8
Showing 10 of 53

US Market Status

Market Closed · Opens Wed (10h 43m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 24, 2026